Interaction between the adrenergic and renin-angiotensin-aldosterone-systems

Area of Science:

• Cardiology
• Neuroendocrinology
• Pharmacology

Background:

• Congestive heart failure (CHF) involves overactivation of the sympathetic nervous system (SNS) and renin-angiotensin-aldosterone-system (RAAS).
• While initially beneficial, sustained activation of SNS and RAAS becomes detrimental in CHF.
• Interactions between these systems are complex and significant in the context of CHF.

Purpose of the Study:

• To elucidate the intricate interactions between the SNS and RAAS in CHF.
• To detail the mechanisms by which SNS influences RAAS activation, specifically renin release.
• To explore the multifaceted role of angiotensin II (AII) in modulating sympathetic activity.

Main Methods:

• Review of existing literature on SNS and RAAS interactions in CHF.
• Analysis of the signaling pathways involving beta 1- and alpha 1-adrenoceptors in renal nerve stimulation.
• Examination of AII's effects on sympathetic neurotransmission, including ganglionic stimulation and noradrenaline release/reuptake.

Main Results:

• SNS stimulates renin release via beta 1-adrenoceptors; higher stimulation recruits antinatriuretic and vasoconstrictor activity via alpha 1-adrenoceptors.
• Angiotensin II enhances sympathetic activity through multiple mechanisms: ganglionic stimulation, increased noradrenaline release, inhibited re-uptake, presynaptic facilitation, and postsynaptic sensitization.
• Presynaptic AII-receptors play a crucial role in mediating AII's effects and are implicated in the action of ACE inhibitors.

Conclusions:

• The interplay between SNS and RAAS is a key pathological feature of CHF.
• Angiotensin II significantly amplifies sympathetic drive through various neuronal mechanisms.
• Understanding these interactions is vital for developing effective therapeutic strategies, such as ACE inhibitors, for managing CHF.